Nortriptyline Hydrochloride
- Product NDC
- 50436-0810
- 11-digit product format
- 504360810
- Labeler code
- 50436
- Product ID
- 50436-0810_6e7cbe57-a125-442b-ae84-6f02bfa5e124
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nortriptyline Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA074132
- Marketing category
- ANDA
- Marketing start
- 1995-04-05
- Marketing end
- 0000-00-00
- Substance
- NORTRIPTYLINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50436-0810 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 50436-0810 | 50436-0810-1 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074132-001 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-002 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-003 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-004 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | RS | 1995-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A074132-001 | AB |
| A074132-002 | AB |
| A074132-003 | AB |
| A074132-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074132-001 | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-002 | NORTRIPTYLINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-003 | NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-004 | NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | RS | 1995-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074132-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | REMEDYREPACK INC. | dd1f4d6f-14cc-44c0-b9d3-bb3d17b557fa | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | REMEDYREPACK INC. | 522d0cd8-d84d-4961-a525-4527fce44c3c | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | a2cf7783-7019-49ea-ab55-796674d94546 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 8eef261f-5c78-a88f-37c4-46e6b0e0f0ee | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Coupler LLC | 4c21abdb-f3e9-9037-e063-6294a90af4b4 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | Direct Rx | 017f7717-e160-4142-9a5a-1a2bd9776707 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | American Health Packaging | d111c36d-98ed-4f0d-97ea-86fe9048deee | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 686d15d0-6434-42ec-8c78-f45d617d294c | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 962f3f54-0556-4509-a231-ca62cb01bec8 | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 43a81887-42b8-43b5-b58a-3f3df2e9949b | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | b58d473a-b19f-4d2a-b1ae-dd398d7a29e1 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | af950b46-07df-4de6-a221-d3d7059b87a1 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | e047f990-c374-4f8f-8583-c615f92545e2 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 2f9fc7a0-163a-4a05-84a7-7999a41ecb1f | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | b387ba49-fd3f-4488-86e8-9b81e85ab232 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | f1868790-c70b-4979-974d-3ce0ffe99e36 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 30263e15-de21-4db4-aceb-59d619909e82 | 2023-03-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50436-0810-1 | EA - Each | 50436-0810 | 4fa65109-ac54-423e-abad-dc36842fd15b | 1 | 2017-08-11 |